Literature DB >> 8565901

Reduction of azo dyes and nitroaromatic compounds by bacterial enzymes from the human intestinal tract.

F Rafii1, C E Cerniglia.   

Abstract

Several anaerobic bacteria from the human intestinal tract are capable of reducing azo dyes and nitropolycyclic aromatic hydrocarbons to the corresponding aromatic amines with enzymes that have azoreductase and nitroreductase activities. The majority of bacteria with these activities belong to the genera Clostridium and Eubacterium. The azoreductases and nitroreductases from three Clostridium strains and one Eubacterium strain were studied. Both enzymes were produced constitutively in each of the bacteria; the enzymes from various bacteria had different electrophoretic mobilities. The azoreductases from all of the bacteria had immunological homology, as was evident from the cross-reactivity of an antibody raised against the azoreductase of C. perfringens with azoreductases from other bacteria. Comparison of azoreductases and nitroreductases showed that they both had identical electrophoretic mobilities on polyacrylamide gels and reacted with the antibody against the azoreductase from C. perfringens. Furthermore, the nitroaromatic compounds competitively inhibited the azoreductase activity. The data indicate that the reduction of both nitroaromatic compounds and azo dyes may be carried out by the same enzyme, which is possibly a flavin adenine dinucleotide dehydrogenase that is synthesized throughout the cell and not associated with any organized subcellular structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8565901      PMCID: PMC1519296          DOI: 10.1289/ehp.95103s417

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  12 in total

1.  Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.

Authors:  W G Levine; H Raza
Journal:  Drug Metab Dispos       Date:  1988 May-Jun       Impact factor: 3.922

2.  Reduction of nitroaromatic compounds by anaerobic bacteria isolated from the human gastrointestinal tract.

Authors:  F Rafil; W Franklin; R H Heflich; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

3.  Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins.

Authors:  R Gingell; R Walker
Journal:  Xenobiotica       Date:  1971-05       Impact factor: 1.908

4.  Metabolism of 6-nitrochrysene by intestinal microflora.

Authors:  B W Manning; W L Campbell; W Franklin; K B Delclos; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1988-01       Impact factor: 4.792

5.  The role of gut flora in the reduction of aromatic nitro-groups.

Authors:  P K Zachariah; M R Juchau
Journal:  Drug Metab Dispos       Date:  1974 Jan-Feb       Impact factor: 3.922

6.  Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora.

Authors:  F Rafii; W Franklin; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1990-07       Impact factor: 4.792

7.  Comparison of the azoreductase and nitroreductase from Clostridium perfringens.

Authors:  F Rafii; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1993-06       Impact factor: 4.792

8.  Metabolism of azo dyes derived from benzidine, 3,3'-dimethyl-benzidine and 3,3'-dimethoxybenzidine to potentially carcinogenic aromatic amines by intestinal bacteria.

Authors:  C E Cerniglia; J P Freeman; W Franklin; L D Pack
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

9.  The stimulation of microsomal azoreduction by flavins.

Authors:  S Fujita; J Peisach
Journal:  Biochim Biophys Acta       Date:  1982-11-24

10.  Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by rat intestinal bacteria.

Authors:  P C Howard; F A Beland; C E Cerniglia
Journal:  Carcinogenesis       Date:  1983-08       Impact factor: 4.944

View more
  10 in total

1.  Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes.

Authors:  Mariya A Smetanina; Mariya Y Pakharukova; Svitlana M Kurinna; Bingning Dong; Juan P Hernandez; David D Moore; Tatyana I Merkulova
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-06       Impact factor: 4.219

Review 2.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

3.  An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol3.

Authors:  Regine Beeck; Annemarie Dols; Felix Schneider; Dariah-Sohreh Seradj; Julius Krause; Philipp Schick; Werner Weitschies
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 4.  Microbial Degradation of Azo Dyes: Approaches and Prospects for a Hazard-Free Conversion by Microorganisms.

Authors:  Anna Christina R Ngo; Dirk Tischler
Journal:  Int J Environ Res Public Health       Date:  2022-04-14       Impact factor: 4.614

Review 5.  Toxicological significance of azo dye metabolism by human intestinal microbiota.

Authors:  Jinhui Feng; Carl E Cerniglia; Huizhong Chen
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

6.  Microbial Biotreatment of Actual Textile Wastewater in a Continuous Sequential Rice Husk Biofilter and the Microbial Community Involved.

Authors:  Jörgen Forss; Markus V Lindh; Jarone Pinhassi; Ulrika Welander
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

Review 7.  Chemical transformation of xenobiotics by the human gut microbiota.

Authors:  Nitzan Koppel; Vayu Maini Rekdal; Emily P Balskus
Journal:  Science       Date:  2017-06-23       Impact factor: 47.728

Review 8.  Human Gut Microbiota and Drug Metabolism.

Authors:  Archana Pant; Tushar K Maiti; Dinesh Mahajan; Bhabatosh Das
Journal:  Microb Ecol       Date:  2022-07-23       Impact factor: 4.192

9.  Gut microbiota-driven drug metabolism in inflammatory bowel disease.

Authors:  Femke Crouwel; Hans J C Buiter; Nanne K de Boer
Journal:  J Crohns Colitis       Date:  2020-07-11       Impact factor: 9.071

Review 10.  DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.

Authors:  Oscar Zaragoza-García; Natividad Castro-Alarcón; Gloria Pérez-Rubio; Iris Paola Guzmán-Guzmán
Journal:  Biomolecules       Date:  2020-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.